MAPT and Alzheimer disease: The HMTM-dependent prevention of tau self-assembly may be effective in slowing the progression of AD and other tauopathies [23], halting the emergence of pathological tau deposits due to the collapse of the intracellular and axonal cytoskeleton [24].